USFDA permits Aurobindo Pharma's ampicillin

USFDA has permitted Aurobindo Pharma's ampicillin injection in single dose and bulk pack formats. The ampicillin has annual sales of $45 million in US market which is a generic equivalent of Sandoz Inc's branded drug Ampicillin and used to treat respiratory tract infections and bacterial meningitis.